PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart

[1]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[2]  Chao Fang,et al.  Cardiomyocyte specific deletion of PP2A causes cardiac hypertrophy. , 2016, American journal of translational research.

[3]  Somy Yoon,et al.  HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases , 2016, Chonnam medical journal.

[4]  Jonathan P. Davis,et al.  Protein phosphatase 2A regulatory subunit B56α limits phosphatase activity in the heart , 2015, Science Signaling.

[5]  W. Ho,et al.  LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential , 2015, Cancer biology & therapy.

[6]  H. Kook,et al.  Role of histone deacetylase 2 and its posttranslational modifications in cardiac hypertrophy , 2015, BMB reports.

[7]  Madhusoodanan Mottamal,et al.  Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents , 2015, Molecules.

[8]  Qingsong Liu,et al.  HDAC2 Selectively Regulates FOXO3a-Mediated Gene Transcription during Oxidative Stress-Induced Neuronal Cell Death , 2015, The Journal of Neuroscience.

[9]  E. Adashi,et al.  Noncommunicable Diseases , 2015, Seminars in Reproductive Medicine.

[10]  Qi Zhang,et al.  Inhibition of protein phosphatase 2A sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via HIF-1α-VEGF mediated angiogenesis. , 2014, Cancer letters.

[11]  K. Lemaire,et al.  The Basic Biology of PP2A in Hematologic Cells and Malignancies , 2014, Front. Oncol..

[12]  Haiyan Xu,et al.  Mitogen-Activated Protein Kinase Phosphatase 3 (MKP-3)–Deficient Mice Are Resistant to Diet-Induced Obesity , 2014, Diabetes.

[13]  J. Min,et al.  Regulation of Acetylation of Histone Deacetylase 2 by p300/CBP-Associated Factor/Histone Deacetylase 5 in the Development of Cardiac Hypertrophy , 2014, Circulation research.

[14]  Y. Xing,et al.  PR65A Phosphorylation Regulates PP2A Complex Signaling , 2014, PloS one.

[15]  S. Batra,et al.  Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. , 2013, Cancer letters.

[16]  J. Davie,et al.  Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors , 2012, Clinical Epigenetics.

[17]  C. D. dos Remedios,et al.  Protein phosphatase 2A affects myofilament contractility in non-failing but not in failing human myocardium , 2011, Journal of Muscle Research and Cell Motility.

[18]  Hyung-Seok Kim,et al.  Casein Kinase-2&agr;1 Induces Hypertrophic Response by Phosphorylation of Histone Deacetylase 2 S394 and its Activation in the Heart , 2011, Circulation.

[19]  I. Rahman,et al.  Protein kinase CK2-mediated phosphorylation of HDAC2 regulates co-repressor formation, deacetylase activity and acetylation of HDAC2 by cigarette smoke and aldehydes. , 2010, Archives of biochemistry and biophysics.

[20]  O. Krämer.  HDAC2: a critical factor in health and disease. , 2009, Trends in pharmacological sciences.

[21]  W-S Xu,et al.  Histone deacetylase inhibitors: Potential in cancer therapy , 2009, Journal of cellular biochemistry.

[22]  I. Morita,et al.  Protein kinase CK2 is a key activator of histone deacetylase in hypoxia‐associated tumors , 2008, International journal of cancer.

[23]  X. Chen,et al.  Krüppel-like Factor 4 Is Acetylated by p300 and Regulates Gene Transcription via Modulation of Histone Acetylation* , 2007, Journal of Biological Chemistry.

[24]  J. Davie,et al.  Differential Distribution of Unmodified and Phosphorylated Histone Deacetylase 2 in Chromatin* , 2007, Journal of Biological Chemistry.

[25]  Xiaoxia Qi,et al.  Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. , 2007, Genes & development.

[26]  W. Wurst,et al.  Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity , 2007, Nature Medicine.

[27]  Wenqing Xu,et al.  Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme , 2007, Nature.

[28]  Yigong Shi,et al.  Structure of the Protein Phosphatase 2A Holoenzyme , 2006, Cell.

[29]  Jason A. Lowry,et al.  Analysis of the structure and function of the transcriptional coregulator HOP. , 2006, Biochemistry.

[30]  D. Dobrev,et al.  Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes. , 2006, Biochemical and biophysical research communications.

[31]  M. Jeong,et al.  Inhibition of Histone Deacetylation Blocks Cardiac Hypertrophy Induced by Angiotensin II Infusion and Aortic Banding , 2005, Circulation.

[32]  Rick B. Vega,et al.  Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5 , 2004, Molecular and Cellular Biology.

[33]  Ulrich Gergs,et al.  Overexpression of the Catalytic Subunit of Protein Phosphatase 2A Impairs Cardiac Function* , 2004, Journal of Biological Chemistry.

[34]  J. Epstein,et al.  Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. , 2003, The Journal of clinical investigation.

[35]  E. Seto,et al.  Regulation of Histone Deacetylase 2 by Protein Kinase CK2* , 2002, The Journal of Biological Chemistry.

[36]  K. Resing,et al.  Phosphatase Inhibition Leads to Histone Deacetylases 1 and 2 Phosphorylation and Disruption of Corepressor Interactions* , 2002, The Journal of Biological Chemistry.

[37]  K. Ahmed,et al.  Joining the cell survival squad: an emerging role for protein kinase CK2. , 2002, Trends in cell biology.

[38]  S. Schreiber,et al.  Histone Deacetylase 1 Phosphorylation Promotes Enzymatic Activity and Complex Formation* , 2001, The Journal of Biological Chemistry.

[39]  E. Olson,et al.  Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Hajjar,et al.  Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy. , 1998, The Journal of clinical investigation.

[41]  Wen‐Ming Yang,et al.  Histone Deacetylases Associated with the mSin3 Corepressor Mediate Mad Transcriptional Repression , 1997, Cell.

[42]  S. Schreiber,et al.  Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase , 1997, Cell.

[43]  A. Tajik,et al.  The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. , 1992, The New England journal of medicine.

[44]  P. Simpson.  Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response. , 1983, The Journal of clinical investigation.

[45]  K. Reddy,et al.  Noncommunicable diseases. , 2013, The New England journal of medicine.

[46]  E. Olson,et al.  The many roles of histone deacetylases in development and physiology: implications for disease and therapy , 2009, Nature Reviews Genetics.

[47]  E. Olson,et al.  Cardiac plasticity. , 2008, The New England journal of medicine.

[48]  J. Neumann.  Altered phosphatase activity in heart failure, influence on Ca2+ movement , 2002, Basic Research in Cardiology.

[49]  W. Schmitz,et al.  Increased expression of cardiac phosphatases in patients with end-stage heart failure. , 1997, Journal of molecular and cellular cardiology.

[50]  W. D. de Jong,et al.  The mechanism of N-terminal acetylation of proteins. , 1985, CRC critical reviews in biochemistry.